Fresenius SE & Co. (OTCMKTS:FSNUY) Sees Large Volume Increase – Here’s Why

Posted by Alphonse Anthony on Jul 25th, 2026

Shares of Fresenius SE & Co. (OTCMKTS:FSNUY – Get Free Report) saw unusually-strong trading volume on Thursday . 751,299 shares were traded during mid-day trading, an increase of 420% from the previous session’s volume of 144,600 shares.The stock last traded at $12.25 and had previously closed at $12.46.

Wall Street Analyst Weigh In

Separately, Morgan Stanley reiterated an “overweight” rating on shares of Fresenius SE & Co. in a report on Tuesday. Three investment analysts have rated the stock with a Buy rating, Based on data from MarketBeat, the company presently has a consensus rating of “Buy”.

Check Out Our Latest Report on FSNUY

Fresenius SE & Co. Price Performance

The company has a 50-day moving average of $11.51 and a 200-day moving average of $12.87. The company has a debt-to-equity ratio of 0.41, a quick ratio of 0.98 and a current ratio of 1.27. The firm has a market capitalization of $28.12 billion, a price-to-earnings ratio of 16.64 and a beta of 0.63.

Fresenius SE & Co. (OTCMKTS:FSNUY – Get Free Report) last announced its earnings results on Wednesday, May 6th. The company reported $0.24 EPS for the quarter, missing the consensus estimate of $0.25 by ($0.01). Fresenius SE & Co. had a return on equity of 10.09% and a net margin of 6.55%.The company had revenue of $6.75 billion for the quarter, compared to analyst estimates of $6.79 billion. As a group, research analysts anticipate that Fresenius SE & Co. will post 1.02 EPS for the current fiscal year.

About Fresenius SE & Co.

(Get Free Report)

Fresenius SE & Co KGaA is a global healthcare group headquartered in Bad Homburg vor der Höhe, Germany. Founded in 1912 by Eduard Fresenius, the company has grown into one of the world’s leading providers of products and services for dialysis, hospitals and outpatient medical care. Trading on major European exchanges and available over the counter in the U.S. as FSNUY, Fresenius SE & Co brings together a portfolio of specialized healthcare businesses under one corporate umbrella.

The company operates through four main business segments.